. Author manuscript; available in PMC: 2014 Dec 1.

Published in final edited form as: Clin Exp Allergy. 2013 Dec;43(12):1342–1350. doi: 10.1111/cea.12156

Table 1.

Subject Characteristics

Characteristic	Healthy controls	Low Eosinophils	High Eosinophils
Number of subjects	20	20	20
Age (years)	27.8 (19–43)	29.2 (20–55)	30.5 (18–57)
Gender: F/M	15/5	14/6	10/10
Duration of asthma: >=6 months to <1 year	not applicable	0	1
>=1 year to <5 years		3	4
>=5 years to <10 years		5	3
>=10 years to <15 years		3	4
>=15 years		9	8
Tobacco use: Former/never smoker	0/20	6/14	6/14
FEV₁ (% predicted)	97.9 (81.7–119.0)	77.1 (61.9–87.7)	75.7 (60.0–88.9)
Reversibility (FEV₁ % change)	not applicable	15.5 (0.6–42.3)	15.7 (7.4–29.9)
PC20 methacholine (mg/ml) Submucosal eosinophils (cells mm⁻²⁾	>16	1.2 (0.5–2.4)(n=2) 0 (0–0.45)	4.1 (1.2–7.0)(n=5) 39.04 (23.43–46.28)
	3.58 (0–6.20)	1.2 (0.5–2.4)(n=2) 0 (0–0.45)	4.1 (1.2–7.0)(n=5) 39.04 (23.43–46.28)

Clinical data are means (ranges), cell data are medians and interquartile ranges